Blog
EQS-News: Krones plans to pay dividend of €2.20 per share for successful 2023 financial year
EQS-News: Krones plans to pay dividend of €2.20 per share for successful 2023 financial year
Travis Perkins: Publication of the 2024 Notice of Annual General Meeting
Travis Perkins: Publication of the 2024 Notice of Annual General Meeting
EQS-News: DATA MODUL able to confirm high sales level in fiscal year 2023 despite fierce cost pressure
EQS-News: DATA MODUL able to confirm high sales level in fiscal year 2023 despite fierce cost pressure
EQS-News: Schaeffler AG successfully places a bond in the amount of 850 million euros
EQS-News: Schaeffler AG successfully places a bond in the amount of 850 million euros
EQS-News: secunet Security Networks AG: Audited annual financial statements and annual report for 2023 and forecast for 2024
EQS-News: secunet Security Networks AG: Audited annual financial statements and annual report for 2023 and forecast for 2024
Fuller, Smith & Turner PLC: Extension of Share Buyback Programme
Fuller, Smith & Turner PLC: Extension of Share Buyback Programme
EQS-News: Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
EQS-News: Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
EQS-News: SGL Carbon achieves annual targets for 2023 and invests more in growth markets
EQS-News: SGL Carbon achieves annual targets for 2023 and invests more in growth markets
EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
EQS-News: Bike24 Holding AG: Strong double-digit growth rates in localized markets and full-bike segment but ongoing weak consumer sentiment in core markets during FY 2023
EQS-News: Bike24 Holding AG: Strong double-digit growth rates in localized markets and full-bike segment but ongoing weak consumer sentiment in core markets during FY 2023
EQS-News: Northern Data Group Publishes Consolidated Financial Statements for the Year Ended December 31, 2022
EQS-News: Northern Data Group Publishes Consolidated Financial Statements for the Year Ended December 31, 2022
Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g
Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
EQS-News: CEWE is planning further turnover and earnings growth in 2024
EQS-News: CEWE is planning further turnover and earnings growth in 2024
ALSO Holding AG: thirteenth consecutive dividend increase
ALSO Holding AG: thirteenth consecutive dividend increase
SFS supports Solvatten in its mission to provide access to clean water for all
SFS supports Solvatten in its mission to provide access to clean water for all
Hong Kong Ferry announces FY2023 annual results Increase in revenue for FY2023 Sales on completed existing units of The Symphonie
Hong Kong Ferry announces FY2023 annual results Increase in revenue for FY2023 Sales on completed existing units of The Symphonie
Fuller, Smith & Turner PLC: TR-1: Standard form for notification of major holdings
Fuller, Smith & Turner PLC: TR-1: Standard form for notification of major holdings
Fuller, Smith & Turner PLC: Transaction in own securities - conclusion and extension of buyback programme
Fuller, Smith & Turner PLC: Transaction in own securities - conclusion and extension of buyback programme
EQS-News: AUSTRIACARD HOLDINGS AG ANNOUNCES FY 2023 RESULTS
EQS-News: AUSTRIACARD HOLDINGS AG ANNOUNCES FY 2023 RESULTS
EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share